Galway Medtech Secures €1.1 Million Grant for US Cancer Device

SymPhysis Medical, a medtech company based in Galway, has been awarded a grant of €1.1 million to further the development of a cancer treatment device in the United States. The funding was secured through the Rhode Island Life Science Hub and will facilitate the advancement of the Releaze Drainage System, designed to treat malignant pleural effusion.

Malignant pleural effusion is a common complication associated with advanced cancers, characterized by fluid accumulation in the chest. This condition often leads to severe breathlessness and pain, resulting in frequent hospital visits for patients. The Releaze Drainage System aims to provide significant relief from these distressing symptoms, improving the quality of life for those affected.

The grant will enable SymPhysis Medical to establish a dedicated team in the US, complete essential testing, and work towards obtaining regulatory clearance for the device. The company emphasizes its commitment to remain headquartered in Galway, where the Releaze system was developed in collaboration with Irish clinicians, nurses, patients, and caregivers.

Strategic Development and Future Plans

With the substantial grant now in place, SymPhysis Medical is poised to accelerate its efforts in the US market. The company plans to assemble a skilled team that will focus on the final stages of testing and the regulatory approval process. This approach not only underscores the significance of the project but also highlights the potential impact of the Releaze Drainage System on patient care.

SymPhysis has expressed confidence that the innovative device will address a critical need in cancer treatment, particularly for those suffering from the debilitating effects of malignant pleural effusion. By leveraging this funding, the company aims to enhance its capabilities and establish a stronger presence in the competitive healthcare landscape of the United States.

As the medtech sector continues to evolve, the development of such devices is increasingly vital. The collaboration between the company and healthcare professionals in Ireland has been instrumental in shaping the Releaze Drainage System, ensuring that it meets the practical needs of patients and caregivers alike.

In summary, the €1.1 million grant awarded to SymPhysis Medical marks a significant step forward in the advancement of cancer treatment technologies. With the potential to alleviate the suffering of many patients, the Releaze Drainage System stands as a testament to innovative healthcare solutions emerging from Galway.